Tg Therapeutics (TGTX) Net Margin (2017 - 2026)
Tg Therapeutics (TGTX) recorded quarterly Net Margin of 9.65% in Q1 2026, down 20.53% quarter-over-quarter from 12.14% in Q4 2025, and up 546.0% on a YoY basis from 1.49% in Q1 2025.
Tg Therapeutics (TGTX) Net Margin (2017 - 2026) Analysis & Trends
Tg Therapeutics' Net Margin history runs 10 years deep, the most recent figure standing at 9.65% for Q1 2026.
- In Q1 2026, Net Margin rose 546.0% year-over-year to 9.65%; the TTM figure through Mar 2026 stood at 66.01% (up 5565.0% YoY), while the FY2025 annual figure was 72.62%, up 6524.0% from the prior year.
- Net Margin was 9.65% for Q1 2026 at Tg Therapeutics, down from 12.14% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 241.73% in Q3 2025 to a low of 100501.25% in Q4 2022.
- Historically, Net Margin has averaged 8849.93% across 5 years, with a median of 4.19% in 2025.
- The sharpest annual moves came in 2022 and 2023: Net Margin sank 9645015 bps in 2022, then soared 10043757 bps in 2023.
- A 5-year view of Net Margin shows it stood at 100501.25% in 2022, then surged by 100 bps to 63.68% in 2023, then jumped by 135 bps to 22.38% in 2024, then plunged by 46 bps to 12.14% in 2025, then dropped by 21 bps to 9.65% in 2026.
- The last three Net Margin figures came in at 9.65% (Q1 2026), 12.14% (Q4 2025), and 241.73% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.82% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Tg Therapeutics | 7.71 Bn | 7.06 Bn | 171.41 Mn | 9.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.65% |
| Dec 31, 2025 | 12.14% |
| Sep 30, 2025 | 241.73% |
| Jun 30, 2025 | 19.99% |
| Mar 31, 2025 | 4.19% |
| Dec 31, 2024 | 22.38% |
| Sep 30, 2024 | 4.63% |
| Jun 30, 2024 | 9.33% |
| Mar 31, 2024 | -16.87% |
| Dec 31, 2023 | -63.68% |
| Sep 30, 2023 | 68.71% |
| Jun 30, 2023 | -296.19% |
| Mar 31, 2023 | -502.78% |
| Dec 31, 2022 | -100,501.25% |
| Sep 30, 2022 | -38,947.87% |
| Jun 30, 2022 | -7,063.64% |
| Mar 31, 2022 | -3,449.21% |
| Dec 31, 2021 | -4,051.10% |
| Sep 30, 2021 | -4,244.63% |
| Jun 30, 2021 | -5,120.71% |